Literature DB >> 19093027

Mouse models of allergic asthma: acute and chronic allergen challenge.

Anthony T Nials1, Sorif Uddin.   

Abstract

Asthma is defined as a chronic inflammatory disease of the airways; however, the underlying physiological and immunological processes are not fully understood. Animal models have been used to elucidate asthma pathophysiology, and to identify and evaluate novel therapeutic targets. Several recent review articles (Epstein, 2004; Lloyd, 2007; Boyce and Austen, 2005; Zosky and Sly, 2007) have discussed the potential value of these models. Allergen challenge models reproduce many features of clinical asthma and have been widely used by investigators; however, the majority involve acute allergen challenge procedures. It is recognised that asthma is a chronic inflammatory disease resulting from continued or intermittent allergen exposure, usually via inhalation, and there has been a recent focus on developing chronic allergen exposure models, predominantly in mice. Here, we review the acute and chronic exposure mouse models, and consider their potential role and impact in the field of asthma research.

Entities:  

Mesh:

Year:  2008        PMID: 19093027      PMCID: PMC2590830          DOI: 10.1242/dmm.000323

Source DB:  PubMed          Journal:  Dis Model Mech        ISSN: 1754-8403            Impact factor:   5.758


  84 in total

1.  Type 2 cytokines in the pathogenesis of sustained airway dysfunction and airway remodeling in mice.

Authors:  Richard Leigh; Russ Ellis; Jennifer N Wattie; Jeremy A Hirota; Klaus I Matthaei; Paul S Foster; Paul M O'Byrne; Mark D Inman
Journal:  Am J Respir Crit Care Med       Date:  2003-12-30       Impact factor: 21.405

2.  TNF-alpha induces the late-phase airway hyperresponsiveness and airway inflammation through cytosolic phospholipase A(2) activation.

Authors:  Il-Whan Choi; Young-Suk Kim; Hyun-Mi Ko; Suhn-Young Im; Jae-Hong Kim; Hye-Jin You; Yong-Chul Lee; Jae-Hoon Lee; Young-Min Park; Hern-Ku Lee
Journal:  J Allergy Clin Immunol       Date:  2005-09       Impact factor: 10.793

3.  The role of interleukin-5 (IL-5) in allergic airway hyperresponsiveness in mice.

Authors:  H Nagai; S Yamaguchi; H Tanaka
Journal:  Ann N Y Acad Sci       Date:  1996-10-31       Impact factor: 5.691

4.  Inhibitory effects of Actinidia polygama extract and cyclosporine A on OVA-induced eosinophilia and bronchial hyperresponsiveness in a murine model of asthma.

Authors:  Young-Cheol Lee; Seung-Hyung Kim; Young-Bae Seo; Seong-Soo Roh; Jang-Cheon Lee
Journal:  Int Immunopharmacol       Date:  2005-11-15       Impact factor: 4.932

5.  CD4(+) T-lymphocytes regulate airway remodeling and hyper-reactivity in a mouse model of chronic asthma.

Authors:  Paul S Foster; Ming Yang; Cristan Herbert; Rakesh K Kumar
Journal:  Lab Invest       Date:  2002-04       Impact factor: 5.662

6.  A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model.

Authors:  William R Henderson; Li-Ou Tang; Shi-Jye Chu; Shih-Ming Tsao; Gertrude K S Chiang; Falaah Jones; Mechthild Jonas; Chong Pae; Huaijing Wang; Emil Y Chi
Journal:  Am J Respir Crit Care Med       Date:  2002-01-01       Impact factor: 21.405

7.  Therapeutic dosing with anti-interleukin-13 monoclonal antibody inhibits asthma progression in mice.

Authors:  Gaoyun Yang; Li Li; Amy Volk; Eva Emmell; Ted Petley; Jill Giles-Komar; Patricia Rafferty; Mani Lakshminarayanan; Don E Griswold; Peter J Bugelski; Anuk M Das
Journal:  J Pharmacol Exp Ther       Date:  2005-01-11       Impact factor: 4.030

8.  Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma.

Authors:  S T Holgate; A G Chuchalin; J Hébert; J Lötvall; G B Persson; K F Chung; J Bousquet; H A Kerstjens; H Fox; J Thirlwell; G Della Cioppa
Journal:  Clin Exp Allergy       Date:  2004-04       Impact factor: 5.018

9.  Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma.

Authors:  C Herbert; A Hettiaratchi; D C Webb; P S Thomas; P S Foster; R K Kumar
Journal:  Clin Exp Allergy       Date:  2008-02-26       Impact factor: 5.018

10.  No audible wheezing: nuggets and conundrums from mouse asthma models.

Authors:  Joshua A Boyce; K Frank Austen
Journal:  J Exp Med       Date:  2005-06-20       Impact factor: 14.307

View more
  134 in total

1.  Eosinophils in the zebrafish: prospective isolation, characterization, and eosinophilia induction by helminth determinants.

Authors:  Keir M Balla; Geanncarlo Lugo-Villarino; Jan M Spitsbergen; David L Stachura; Yan Hu; Karina Bañuelos; Octavio Romo-Fewell; Raffi V Aroian; David Traver
Journal:  Blood       Date:  2010-08-16       Impact factor: 22.113

2.  Alveolar macrophages stimulate enhanced cytokine production by pulmonary CD4+ T-lymphocytes in an exacerbation of murine chronic asthma.

Authors:  Cristan Herbert; Melissa M Scott; Kim H Scruton; Rylie P Keogh; Kristy C Yuan; Kenneth Hsu; Jessica S Siegle; Nicodemus Tedla; Paul S Foster; Rakesh K Kumar
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

Review 3.  G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.

Authors:  Stacy Gelhaus Wendell; Hao Fan; Cheng Zhang
Journal:  Pharmacol Rev       Date:  2020-01       Impact factor: 25.468

4.  Experimental Modeling of Eosinophil-Associated Diseases.

Authors:  Sathisha Upparahalli Venkateshaiah; Murli Manohar; Hemanth Kumar Kandikattu; Anil Mishra
Journal:  Methods Mol Biol       Date:  2021

Review 5.  Animal models of asthma.

Authors:  Jason H T Bates; Mercedes Rincon; Charles G Irvin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-06-26       Impact factor: 5.464

6.  Antigen-induced mast cell expansion and bronchoconstriction in a mouse model of asthma.

Authors:  Shannon Li; Minara Aliyeva; Nirav Daphtary; Rebecca A Martin; Matthew E Poynter; Shannon F Kostin; Jos L van der Velden; Alexandra M Hyman; Christopher S Stevenson; Jonathan E Phillips; Lennart K A Lundblad
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-27       Impact factor: 5.464

7.  Multi-allergen challenge stimulates steriod-resistant airway inflammation via NF-κB-mediated IL-8 expression.

Authors:  Renping Liu; Jinye Bai; Guoshun Xu; Lingling Xuan; Tianqi Zhang; Aiming Meng; Qi Hou
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

Review 8.  Key mediators in the immunopathogenesis of allergic asthma.

Authors:  Sannette Hall; Devendra K Agrawal
Journal:  Int Immunopharmacol       Date:  2014-06-13       Impact factor: 4.932

9.  Selective targeting of CREB-binding protein/β-catenin inhibits growth of and extracellular matrix remodelling by airway smooth muscle.

Authors:  Tim Koopmans; Stijn Crutzen; Mark H Menzen; Andrew J Halayko; Tillie-Louise Hackett; Darryl A Knight; Reinoud Gosens
Journal:  Br J Pharmacol       Date:  2016-10-25       Impact factor: 8.739

10.  Development of a bronchospasm device model.

Authors:  Asumi Sugiura; Kaneyuki Kawamae
Journal:  J Anesth       Date:  2014-07-04       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.